Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 9/20 | 0.45 |
| ▸ | HTR2C | P28335 | 7/20 | 0.42 |
| ▸ | HEXA | P06865 | 1/20 | 0.40 |
| ▸ | HEXB | P07686 | 1/20 | 0.40 |
| ▸ | HTR2B | P41595 | 5/20 | 0.38 |
| ▸ | EGFR | P00533 | 2/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.35 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.34 |
| ▸ | KMO | O15229 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7798203 | 0.77 | HEXA (0.37) | HTR2AHTR2CHEXAHEXBEGFR | |
| SCHEMBL30839555 | 0.74 | CYP1A2 (0.57) | HTR2AHTR2CEGFRADRA2APOLB | |
| SCHEMBL23370339 | 0.74 | HTR2A (0.35) | HTR2AHTR2CHTR2BADRA2AKMO | |
| SCHEMBL2272282 | 0.73 | KDM4E (0.42) | HTR2AHTR2CHTR2BKDM4E | |
| SCHEMBL24746489 | 0.72 | HTR2C (0.59) | HTR2AHTR2CHEXAHEXBHTR2B | |
| SCHEMBL4956856 | 0.70 | ADRA2A (0.37) | HTR2AHTR2CHTR2BADRA2AKDM4E | |
| SCHEMBL31079475 | 0.70 | HTR2A (0.66) | HTR2AHTR2CHTR2BEGFRADRA2A | |
| SCHEMBL30498101 | 0.69 | CASR (0.38) | HTR2AHTR2CHTR2BEGFRKDM4E | |
| SCHEMBL27199656 | 0.69 | CASR (0.38) | HTR2AHTR2CHTR2BEGFRKDM4E | |
| SCHEMBL25975946 | 0.68 | KMO (0.47) | HTR2AHTR2CEGFRKCNH2MCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240342126-A1 | HALLUCINOGEN-FATTY ACID COMBINATION | MINDSET PHARMA INC. (CA) | 2024-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240342126-A1 | HALLUCINOGEN-FATTY ACID COMBINATION | FAAH, HTR5A, FAAH2 | HTR2A 8/4885HTR2C 5/4885HEXA 423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.